+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Osteobiologics Market by Product, Technique, Processing Method, Material Sourced, Application, End-User - Global Forecast 2025-2030- Product Image
Osteobiologics Market by Product, Technique, Processing Method, Material Sourced, Application, End-User - Global Forecast 2025-2030- Product Image
Sale

Osteobiologics Market by Product, Technique, Processing Method, Material Sourced, Application, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 187 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 4968632
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Osteobiologics Market grew from USD 1.29 billion in 2023 to USD 1.36 billion in 2024. It is expected to continue growing at a CAGR of 5.47%, reaching USD 1.88 billion by 2030.

Osteobiologics is a specialized segment within the broader biopharmaceutical industry focused on using biological substances to support bone repair and regeneration, primarily in orthopedic and dental applications. The necessity of osteobiologics stems from the increasing incidences of bone-related injuries and conditions, such as fractures, osteoporosis, and spinal disorders, which demand effective treatment solutions. Applications of osteobiologics encompass bone graft substitutes, growth factors, and cell-based products used in surgeries ranging from spinal fusions to the repair of bone defects. End-users predominantly include hospitals, orthopedic clinics, and dental practices. Market insights reveal that the growing aging population, rising prevalence of orthopedic diseases, and advances in biotechnology are significant growth drivers. Moreover, the shift towards minimally invasive surgeries has heightened the demand for bone graft substitutes due to reduced recovery times and enhanced efficiency in surgeries.

Emerging opportunities in the market include the development of next-generation biocompatible materials and personalized medicine approaches leveraging genetic insights to create tailored osteobiologic products. However, limitations such as high costs of development, stringent regulatory environments, and potential ethical concerns regarding the use of biological materials pose challenges to market growth. Additionally, the threat of infection and rejection remains a clinical concern, necessitating further innovation. The best possible areas of innovation and research include the enhancement of synthetic bone graft substitutes with superior integration capabilities and the exploration of advanced delivery systems for growth factors to optimize healing efficacy.

Business growth can also stem from strategic partnerships with academic institutions and biotechnology firms to leverage cutting-edge research and development. The market is characterized by a high degree of competition, with major market players focusing on mergers, acquisitions, and collaborations to expand their portfolio and global reach. Tailoring products for emerging markets and focusing on scalable manufacturing processes will further enhance market penetration and sustainability.

Understanding Market Dynamics in the Osteobiologics Market

The Osteobiologics Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing aging population globally and rising prevalence of bone-related conditions
    • Rising surgical interventions involving bones and joints necessitating advanced bone healing solutions
    • Growing demand for minimally invasive treatments
  • Market Restraints
    • Variability in clinical outcomes affecting the credibility and acceptance of products
  • Market Opportunities
    • Development of patient-specific treatments using 3D printing and tissue engineering
    • Expansion of product lines to include novel materials and combinations of biological agents for enhanced efficacy
  • Market Challenges
    • Limited awareness and dearth of skilled professionals

Exploring Porter’s Five Forces for the Osteobiologics Market

Porter’s Five Forces framework further strengthens the insights of the Osteobiologics Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Osteobiologics Market

External macro-environmental factors deeply influence the performance of the Osteobiologics Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Osteobiologics Market

The Osteobiologics Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Osteobiologics Market

The Osteobiologics Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Osteobiologics Market

The Osteobiologics Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Osteobiologics Market, highlighting leading vendors and their innovative profiles. These include Advancells Diagnostics, Aetna Inc., AlloSource, Anika Therapeutics, Inc., Arthrex, Inc., Australian Biotechnologies Pty Ltd, Baxter International Inc., Biogennix, LLC., CONMED Corporation, Exactech, Inc.(parent company TPG Capital), Geistlich Pharma AG, Integra LifeSciences Holdings Corporation, KLS Martin Group, KNITPRO INTERNATIONAL, Medical Device Business Services, Inc., Medtronic Plc, MTF Biologics, NuVasive, Inc., Orthofix Medical Inc., Osiris Therapeutics, Inc. (acquired by Smith & Nephew), ROYAL BIOLOGICS, RTI Surgical Holdings, Inc.(acquired by Montagu Private Equity LLP), Stryker Corporation, SynerHeal Pharmaceuticals, Wright Medical Group N.V., and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Osteobiologics Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Allografts
    • Bone Marrow Aspirate Concentrate
    • Bone Morphogenic Protein
    • Demineralized Bone Matrices
    • Plasma-Rich Protein
    • Synthetic Orthobiologics
    • Visco-Supplementation Products
  • Technique
    • Bioceramics & Composites
    • Injectable Biomaterials
    • Orthopedic Biomaterial Implants
  • Processing Method
    • Demineralized
    • Mineralized
    • Osteoconductive
    • Osteoinductive
  • Material Sourced
    • Natural
    • Synthetic
  • Application
    • Bone Infection & Tumors
    • Dental Bone Grafting
    • Joint Reconstruction
    • Spinal Fusion
    • Trauma & Non-Union Fractures
  • End-User
    • Hospitals
    • Research & Academic Institutes
    • Specialty Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing aging population globally and rising prevalence of bone-related conditions
5.1.1.2. Rising surgical interventions involving bones and joints necessitating advanced bone healing solutions
5.1.1.3. Growing demand for minimally invasive treatments
5.1.2. Restraints
5.1.2.1. Variability in clinical outcomes affecting the credibility and acceptance of products
5.1.3. Opportunities
5.1.3.1. Development of patient-specific treatments using 3D printing and tissue engineering
5.1.3.2. Expansion of product lines to include novel materials and combinations of biological agents for enhanced efficacy
5.1.4. Challenges
5.1.4.1. Limited awareness and dearth of skilled professionals
5.2. Market Segmentation Analysis
5.2.1. Product: Emerging usage of allografts owing to their osteoconductive properties that support new bone growth
5.2.2. Application: Need for osteobiologic solutions that combine antimicrobial and regenerative properties for targeting bone infection & tumors
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Osteobiologics Market, by Product
6.1. Introduction
6.2. Allografts
6.3. Bone Marrow Aspirate Concentrate
6.4. Bone Morphogenic Protein
6.5. Demineralized Bone Matrices
6.6. Plasma-Rich Protein
6.7. Synthetic Orthobiologics
6.8. Visco-Supplementation Products
7. Osteobiologics Market, by Technique
7.1. Introduction
7.2. Bioceramics & Composites
7.3. Injectable Biomaterials
7.4. Orthopedic Biomaterial Implants
8. Osteobiologics Market, by Processing Method
8.1. Introduction
8.2. Demineralized
8.3. Mineralized
8.4. Osteoconductive
8.5. Osteoinductive
9. Osteobiologics Market, by Material Sourced
9.1. Introduction
9.2. Natural
9.3. Synthetic
10. Osteobiologics Market, by Application
10.1. Introduction
10.2. Bone Infection & Tumors
10.3. Dental Bone Grafting
10.4. Joint Reconstruction
10.5. Spinal Fusion
10.6. Trauma & Non-Union Fractures
11. Osteobiologics Market, by End-User
11.1. Introduction
11.2. Hospitals
11.3. Research & Academic Institutes
11.4. Specialty Clinics
12. Americas Osteobiologics Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Osteobiologics Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Osteobiologics Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. Market Share Analysis, 2023
15.2. FPNV Positioning Matrix, 2023
15.3. Competitive Scenario Analysis
15.3.1. Biogennix launches Agilon Surgical Matrix made from bovine collagen
15.3.2. Biogennix receives FDA clearance for Agilon and Morpheus Moldable products
15.3.3. Irvine-based biogennix launches osteospan fiber matrix to enhance surgical outcomes
15.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. OSTEOBIOLOGICS MARKET RESEARCH PROCESS
FIGURE 2. OSTEOBIOLOGICS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL OSTEOBIOLOGICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2023 VS 2030 (%)
FIGURE 11. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2023 VS 2030 (%)
FIGURE 13. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 15. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 17. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. UNITED STATES OSTEOBIOLOGICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 21. UNITED STATES OSTEOBIOLOGICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 26. OSTEOBIOLOGICS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 27. OSTEOBIOLOGICS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. OSTEOBIOLOGICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL OSTEOBIOLOGICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. OSTEOBIOLOGICS MARKET DYNAMICS
TABLE 7. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY BONE MARROW ASPIRATE CONCENTRATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENIC PROTEIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY PLASMA-RICH PROTEIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC ORTHOBIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY VISCO-SUPPLEMENTATION PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY BIOCERAMICS & COMPOSITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY INJECTABLE BIOMATERIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY ORTHOPEDIC BIOMATERIAL IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY DEMINERALIZED, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY MINERALIZED, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY OSTEOCONDUCTIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY OSTEOINDUCTIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY NATURAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY BONE INFECTION & TUMORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY DENTAL BONE GRAFTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY JOINT RECONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY SPINAL FUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY TRAUMA & NON-UNION FRACTURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
TABLE 48. ARGENTINA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 56. CANADA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 57. CANADA OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 58. CANADA OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 59. CANADA OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
TABLE 60. CANADA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. CANADA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 62. MEXICO OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 63. MEXICO OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 64. MEXICO OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 65. MEXICO OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
TABLE 66. MEXICO OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. MEXICO OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES OSTEOBIOLOGICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 75. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 76. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 77. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 78. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
TABLE 79. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 82. AUSTRALIA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 83. AUSTRALIA OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 84. AUSTRALIA OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 85. AUSTRALIA OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
TABLE 86. AUSTRALIA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. AUSTRALIA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 88. CHINA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 89. CHINA OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 90. CHINA OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 91. CHINA OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
TABLE 92. CHINA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. CHINA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 94. INDIA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 95. INDIA OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 96. INDIA OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 97. INDIA OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
TABLE 98. INDIA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. INDIA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 100. INDONESIA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 101. INDONESIA OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 102. INDONESIA OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 103. INDONESIA OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
TABLE 104. INDONESIA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. INDONESIA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 106. JAPAN OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 107. JAPAN OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 108. JAPAN OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 109. JAPAN OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
TABLE 110. JAPAN OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. JAPAN OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 112. MALAYSIA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 113. MALAYSIA OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 114. MALAYSIA OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 115. MALAYSIA OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
TABLE 116. MALAYSIA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. MALAYSIA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 118. PHILIPPINES OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 119. PHILIPPINES OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 120. PHILIPPINES OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 121. PHILIPPINES OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
TABLE 122. PHILIPPINES OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. PHILIPPINES OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 124. SINGAPORE OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 125. SINGAPORE OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 126. SINGAPORE OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 127. SINGAPORE OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
TABLE 128. SINGAPORE OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. SINGAPORE OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. SOUTH KOREA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 131. SOUTH KOREA OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 132. SOUTH KOREA OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 133. SOUTH KOREA OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
TABLE 134. SOUTH KOREA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. SOUTH KOREA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 136. TAIWAN OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 137. TAIWAN OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 138. TAIWAN OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 139. TAIWAN OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
TABLE 140. TAIWAN OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. TAIWAN OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 142. THAILAND OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 143. THAILAND OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 144. THAILAND OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 145. THAILAND OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
TABLE 146. THAILAND OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. THAILAND OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 148. VIETNAM OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 149. VIETNAM OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 150. VIETNAM OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 151. VIETNAM OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
TABLE 152. VIETNAM OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. VIETNAM OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 161. DENMARK OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 162. DENMARK OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 163. DENMARK OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 164. DENMARK OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
TABLE 165. DENMARK OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. DENMARK OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 167. EGYPT OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 168. EGYPT OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 169. EGYPT OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 170. EGYPT OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
TABLE 171. EGYPT OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. EGYPT OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 173. FINLAND OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 174. FINLAND OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 175. FINLAND OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 176. FINLAND OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
TABLE 177. FINLAND OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. FINLAND OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 179. FRANCE OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 180. FRANCE OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 181. FRANCE OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 182. FRANCE OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
TABLE 183. FRANCE OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. FRANCE OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 185. GERMANY OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 186. GERMANY OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 187. GERMANY OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 188. GERMANY OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
TABLE 189. GERMANY OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. GERMANY OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 191. ISRAEL OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 192. ISRAEL OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 193. ISRAEL OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 194. ISRAEL OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
TABLE 195. ISRAEL OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 196. ISRAEL OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 197. ITALY OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 198. ITALY OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 199. ITALY OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 200. ITALY OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
TABLE 201. ITALY OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 202. ITALY OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 203. NETHERLANDS OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 204. NETHERLANDS OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 205. NETHERLANDS OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 206. NETHERLANDS OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
TABLE 207. NETHERLANDS OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. NETHERLANDS OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 209. NIGERIA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 211. NIGERIA OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 212. NIGERIA OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
TABLE 213. NIGERIA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 214. NIGERIA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 215. NORWAY OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 216. NORWAY OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 217. NORWAY OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 218. NORWAY OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
TABLE 219. NORWAY OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 220. NORWAY OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 221. POLAND OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 222. POLAND OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 223. POLAND OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 224. POLAND OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
TABLE 225. POLAND OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 226. POLAND OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 227. QATAR OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 228. QATAR OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 229. QATAR OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 230. QATAR OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
TABLE 231. QATAR OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 232. QATAR OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 233. RUSSIA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 234. RUSSIA OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 235. RUSSIA OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 236. RUSSIA OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
TABLE 237. RUSSIA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 238. RUSSIA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 240. SAUDI ARABIA OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 242. SAUDI ARABIA OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 244. SAUDI ARABIA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 246. SOUTH AFRICA OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 248. SOUTH AFRICA OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 250. SOUTH AFRICA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 251. SPAIN OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 252. SPAIN OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 253. SPAIN OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 254. SPAIN OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
TABLE 255. SPAIN OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 256. SPAIN OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 257. SWEDEN OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 258. SWEDEN OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 259. SWEDEN OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 260. SWEDEN OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
TABLE 261. SWEDEN OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 262. SWEDEN OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 263. SWITZERLAND OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 264. SWITZERLAND OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 265. SWITZERLAND OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 266. SWITZERLAND OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
TABLE 267. SWITZERLAND OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 268. SWITZERLAND OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 269. TURKEY OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 270. TURKEY OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 271. TURKEY OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 272. TURKEY OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
TABLE 273. TURKEY OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 274. TURKEY OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 282. UNITED KINGDOM OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 284. UNITED KINGDOM OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 286. UNITED KINGDOM OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 287. OSTEOBIOLOGICS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 288. OSTEOBIOLOGICS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Osteobiologics market, which are profiled in this report, include:
  • Advancells Diagnostics
  • Aetna Inc.
  • AlloSource
  • Anika Therapeutics, Inc.
  • Arthrex, Inc.
  • Australian Biotechnologies Pty Ltd
  • Baxter International Inc.
  • Biogennix, LLC.
  • CONMED Corporation
  • Exactech, Inc.(parent company TPG Capital)
  • Geistlich Pharma AG
  • Integra LifeSciences Holdings Corporation
  • KLS Martin Group
  • KNITPRO INTERNATIONAL
  • Medical Device Business Services, Inc.
  • Medtronic Plc
  • MTF Biologics
  • NuVasive, Inc.
  • Orthofix Medical Inc.
  • Osiris Therapeutics, Inc. (acquired by Smith & Nephew)
  • ROYAL BIOLOGICS
  • RTI Surgical Holdings, Inc.(acquired by Montagu Private Equity LLP)
  • Stryker Corporation
  • SynerHeal Pharmaceuticals
  • Wright Medical Group N.V.
  • Zimmer Biomet Holdings, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages187
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 1.36 Billion
Forecasted Market Value ( USD ) by 2030 $ 1.88 Billion
Compound Annual Growth Rate5.4%
Regions CoveredGlobal
No. of Companies Mentioned27

Related Topics

Related Reports

Ortho And Osteobiologics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Ortho And Osteobiologics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 98 Pages
  • Global
From
United Kingdom Ortho and Osteobiologics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2032 - Product Image

United Kingdom Ortho and Osteobiologics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2032

  • Report
  • 80 Pages
  • United Kingdom
From
United Arab Emirates Ortho and Osteobiologics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2032 - Product Image

United Arab Emirates Ortho and Osteobiologics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2032

  • Report
  • 80 Pages
  • United Arab Emirates United Arab Emirates
From
United States Orthopedic Biomaterials Market Size, Share & Trends Analysis | 2024-2030 | MedSuite | Includes: Bone Graft Substitutes, Orthopedic Growth Factors, Cellular Allografts, and 3 more - Product Image

United States Orthopedic Biomaterials Market Size, Share & Trends Analysis | 2024-2030 | MedSuite | Includes: Bone Graft Substitutes, Orthopedic Growth Factors, Cellular Allografts, and 3 more

  • Report
  • 388 Pages
  • United States
From
Bisphosphonates Market by Therapeutic Areas, Mode of Delivery, Application, Distribution Channel - Global Forecast 2025-2030 - Product Image

Bisphosphonates Market by Therapeutic Areas, Mode of Delivery, Application, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From

About the Osteobiologics Market

The Osteobiologics market is a subset of the biopharmaceuticals industry, focusing on the development of treatments and therapies for bone-related diseases and conditions. Osteobiologics products are typically used to treat bone fractures, osteoporosis, and other bone-related diseases. These products are typically derived from natural sources, such as bone marrow, and are designed to promote bone healing and regeneration. Osteobiologics products are typically used in combination with other treatments, such as physical therapy, to provide a comprehensive approach to bone healing and regeneration. Osteobiologics products are also used to treat bone-related conditions such as osteoarthritis, bone tumors, and bone infections. Some of the companies in the Osteobiologics market include Stryker Corporation, Zimmer Biomet, Medtronic, Smith & Nephew, and Orthofix International. These companies are involved in the development, manufacture, and marketing of Osteobiologics products. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.